Morgan Stanley Alpha Teknova, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Morgan Stanley holds 114,967 shares of TKNO stock, worth $664,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,967

Previous 79,244 45.08%

Holding current value

$664,509

Previous $411,000 37.23%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$4.51 - $7.06 $161,110 - $252,204	35,723 Added 45.08%	114,967 $564,000
Q1 2025 May 15, 2025	BUY	$5.19 - $9.61 $260,885 - $483,065	50,267 Added 173.47%	79,244 $411,000
Q4 2024 Feb 14, 2025	SELL	$4.55 - $8.97 $31,881 - $62,852	-7,007 Reduced 19.47%	28,977 $241,000
Q3 2024 May 14, 2025	SELL	$1.2 - $5.17 $10,519 - $45,320	-8,766 Reduced 19.59%	35,984 $174,000
Q3 2024 Nov 14, 2024	SELL	$1.2 - $5.17 $10,519 - $45,320	-8,766 Reduced 19.59%	35,984 $174,000
Q2 2024 May 14, 2025	BUY	$1.29 - $2.81 $20,347 - $44,322	15,773 Added 54.43%	44,750 $61,000
Q2 2024 Oct 17, 2024	SELL	$1.29 - $2.81 $65,623 - $142,947	-50,871 Reduced 53.2%	44,750 $61,000
Q2 2024 Aug 14, 2024	SELL	$1.29 - $2.81 $65,623 - $142,947	-50,871 Reduced 53.2%	44,750 $61,000
Q1 2024 Oct 17, 2024	BUY	$2.41 - $3.88 $122,599 - $197,379	50,871 Added 113.68%	95,621 $253,000
Q1 2024 Aug 16, 2024	SELL	$2.41 - $3.88 $19,913 - $32,060	-8,263 Reduced 7.95%	95,621 $253,000
Q1 2024 May 15, 2024	SELL	$2.41 - $3.88 $19,913 - $32,060	-8,263 Reduced 7.95%	95,621 $253,000
Q4 2023 Aug 16, 2024	BUY	$1.85 - $3.73 $109,397 - $220,569	59,134 Added 132.14%	103,884 $387,000
Q4 2023 Feb 13, 2024	BUY	$1.85 - $3.73 $189,105 - $381,276	102,219 Added 6139.28%	103,884 $387,000
Q3 2023 Nov 15, 2023	SELL	$1.66 - $3.83 $926 - $2,137	-558 Reduced 25.1%	1,665 $4,000
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.98 $6,575 - $14,538	-3,653 Reduced 62.17%	2,223 $5,000
Q1 2023 May 15, 2023	BUY	$2.74 - $6.25 $12,502 - $28,518	4,563 Added 347.52%	5,876 $17,000
Q4 2022 Feb 14, 2023	SELL	$3.23 - $5.64 $21,796 - $38,058	-6,748 Reduced 83.71%	1,313 $7,000
Q3 2022 Nov 14, 2022	BUY	$3.34 - $9.2 $1,446 - $3,983	433 Added 5.68%	8,061 $27,000
Q2 2022 Oct 27, 2022	BUY	$6.39 - $16.24 $10,671 - $27,120	1,670 Added 28.03%	7,628 $64,000
Q2 2022 Aug 15, 2022	BUY	$6.39 - $16.24 $10,671 - $27,120	1,670 Added 28.03%	7,628 $64,000
Q1 2022 Oct 27, 2022	SELL	$12.79 - $21.64 $21,359 - $36,138	-1,670 Reduced 21.89%	5,958 $83,000
Q1 2022 May 13, 2022	SELL	$12.79 - $21.64 $2,174 - $3,678	-170 Reduced 2.77%	5,958 $83,000
Q4 2021 Feb 14, 2022	BUY	$17.49 - $26.72 $91,297 - $139,478	5,220 Added 574.89%	6,128 $125,000
Q3 2021 Nov 15, 2021	BUY	$17.47 - $27.49 $15,862 - $24,960	908 New	908 $22,000

Others Institutions Holding TKNO

# of Institutions

Shares Held

7.3M

Call Options Held

Put Options Held

View Full List

About Alpha Teknova, Inc.

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $162M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

More about TKNO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account